Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.

Détails

Ressource 1Télécharger: 32790855_BIB_4B348B262495.pdf (400.45 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
ID Serval
serval:BIB_4B348B262495
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.
Périodique
Blood
Auteur⸱e⸱s
Stalder G., Alberio L.
ISSN
1528-0020 (Electronic)
ISSN-L
0006-4971
Statut éditorial
Publié
Date de publication
13/08/2020
Peer-reviewed
Oui
Volume
136
Numéro
7
Pages
915
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Mots-clé
Aged, 80 and over, Antiviral Agents/administration & dosage, Antiviral Agents/adverse effects, Betacoronavirus/drug effects, Betacoronavirus/immunology, Betacoronavirus/pathogenicity, Coronavirus Infections/diagnostic imaging, Coronavirus Infections/drug therapy, Coronavirus Infections/pathology, Coronavirus Infections/virology, Drug Combinations, Eryptosis/drug effects, Erythrocytes/drug effects, Erythrocytes/pathology, Erythrocytes/virology, Humans, Lopinavir/administration & dosage, Lopinavir/adverse effects, Lung/diagnostic imaging, Lung/pathology, Lung/virology, Male, Pandemics, Pneumonia, Viral/diagnostic imaging, Pneumonia, Viral/drug therapy, Pneumonia, Viral/pathology, Pneumonia, Viral/virology, Ritonavir/administration & dosage, Ritonavir/adverse effects, Tomography, X-Ray Computed
Pubmed
Web of science
Open Access
Oui
Création de la notice
07/09/2020 10:49
Dernière modification de la notice
30/04/2021 6:10
Données d'usage